For example, according to data from the National Cancer Institute (U.S.), 64.6% of people with diffuse large B-cell lymphoma are alive five years after diagnosis. On the other hand, data show 90% of people with follicular lymphoma are alive five years after diagnosis.

Below are the 5-year relative survival rates for the two most common types of NHL in the United States – diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) – based on people diagnosed between 2012 and 2018.

B Cell Lymphoma Life Expectancy: The R-IPI then identifies three prognostic groups according to points. 0 points: Prognosis, Very good (4-year progression-free survival 94%, overall survival, 94%) 1-2 points: Prognosis, Good (4-year PFS 80%, OS 79%)

2023年9月25日 · What Are the Survival Rates for NHL? Doctors often use a statistic called the 5-year relative survival rate to talk about an NHL prognosis. This means they compare the percentage of people with...

Almost 75 out of 100 people (almost 75%) survive for 5 years or more after they are diagnosed. This is a group of slow growing B cell lymphomas.

Standard treatment for DLBCL generally involves months of conventional chemotherapy, and overall cure rates in the last 15 years have been about 70%. Diffuse large B-cell lymphoma has long been treated as a single disease, but it is now categorized into many different subtypes based on their molecular features.

People with B-cell lymphomas often have a better prognosis than those with T-cell lymphomas. Of the 2 most common types of B-cell lymphoma, follicular lymphoma generally has a better prognosis than diffuse large B-cell lymphoma (DLBCL).

2024年3月25日 · Prognostic factors may include your personal risk factors such as family history of lymphoma, your overall health, and the characteristics of your DLBCL. Based on studies between 2012 and 2018, 65 percent of people with DLBCL live for at least five years after diagnosis. Younger adults tend to have a better outlook compared with older adults.

2022年6月30日 · After being diagnosed with B-cell lymphoma, many people want to better understand their prognosis (outlook). Lymphoma prognosis describes how the disease is likely to progress and estimates a person’s chances of recovering. One way that researchers measure prognosis is through survival rates.

In most children and young adults with B-cell lymphoma, the cause is unknown. However, people who have DNA repair defects or immune deficiencies, or those who take immunosuppressive medications, are at higher risk for developing this type of cancer.